John M. Sprague - Feb 24, 2022 Form 4/A - Amendment Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Financial Officer
Signature
/s/ Michael Gibbs, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 24, 2022
Transactions value $
-$24,688
Form type
4/A - Amendment
Date filed
3/29/2022, 04:23 PM
Date Of Original Report
Feb 28, 2022
Previous filing
Mar 29, 2022
Next filing
Apr 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +146K +282.19% 197K Feb 24, 2022 Direct F1, F2
transaction TTOO Common Stock Tax liability -$24.7K -55K -27.87% $0.45 142K Feb 24, 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -146K -33.33% $0.00 291K Feb 24, 2022 Common Stock 146K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 191,204.
F3 55,008 shares of common stock were automatically withheld at vesting to cover required tax withholding.
F4 The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 136,196.
F5 On February 24, 2021 the reporting person was granted 437,158 RSU's that vest in three equal installments commencing on February 24, 2022.